6677 Stock Overview
Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Anxo Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$45.35 |
| 52 Week High | NT$77.20 |
| 52 Week Low | NT$42.90 |
| Beta | -0.041 |
| 1 Month Change | -0.87% |
| 3 Month Change | -1.31% |
| 1 Year Change | -6.78% |
| 3 Year Change | 70.67% |
| 5 Year Change | 28.09% |
| Change since IPO | -5.66% |
Recent News & Updates
Shareholder Returns
| 6677 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | 2.8% | -1.5% | -0.6% |
| 1Y | -6.8% | 8.8% | 29.2% |
Return vs Industry: 6677 underperformed the TW Pharmaceuticals industry which returned 8.8% over the past year.
Return vs Market: 6677 underperformed the TW Market which returned 29.2% over the past year.
Price Volatility
| 6677 volatility | |
|---|---|
| 6677 Average Weekly Movement | 3.1% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6677 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6677's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | n/a | www.anxo.com.tw |
Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroenterology, anti-infectives/anti-viruses, hemodialysis/urinary system, respiratory system/antihistamine, analgesics, and others; and injections. The company was founded in 2003 and is headquartered in Taipei, Taiwan.
Anxo Pharmaceutical Co., Ltd. Fundamentals Summary
| 6677 fundamental statistics | |
|---|---|
| Market cap | NT$2.52b |
| Earnings (TTM) | NT$33.28m |
| Revenue (TTM) | NT$941.25m |
75.9x
P/E Ratio2.7x
P/S RatioIs 6677 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6677 income statement (TTM) | |
|---|---|
| Revenue | NT$941.25m |
| Cost of Revenue | NT$537.14m |
| Gross Profit | NT$404.11m |
| Other Expenses | NT$370.83m |
| Earnings | NT$33.28m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.60 |
| Gross Margin | 42.93% |
| Net Profit Margin | 3.54% |
| Debt/Equity Ratio | 99.8% |
How did 6677 perform over the long term?
See historical performance and comparison